相关实验视频

Updated: Jan 18, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

蜂蜜糊对缓解洛佩拉胺引起的便秘的作用,与胃肠功能和肠道微环境的调节有关

Danni Chang¹, Fanhua Wu¹, Yu Yang¹

¹College of Food Science and Technology, Northwest University, 229 North TaiBai Road, Xi'an 710069, China.

Food research international (Ottawa, Ont.)

|September 9, 2025

概括

一种新的蜂蜜糊通过改善肠道细菌并产生有益的短链脂肪酸 (SCFA) 来有效缓解便秘. 这种自然组合为控制便秘和相关肠道健康问题提供了有希望的方法.

科学领域:

胃肠病学胃肠病学
微生物学微生物学
营养科学营养科学

背景情况:

功能性胃肠道疾病通常通过饮食干预来管理.
蜂蜜和草具有已知的药性质,但它们对便秘的协同作用尚不清楚.
了解自然疗法背后的机制对于开发有效的治疗方法至关重要.

研究的目的:

为了研究蜂蜜糊对洛佩拉胺诱导的缓慢过渡性便秘的预防作用.
综合分析蜂蜜糊对胃肠功能和肠道微环境的影响.
阐明底层的调节机制,包括神经递质和信号通路.

主要方法:

使用蜂蜜和杏仁的蜂蜜糊的配方.
在使用洛佩拉米德的模型系统中诱导缓慢过渡性便秘.
评估便特性,胃肠机动性和组织学变化.
对胃肠道神经递质和关键信号通路的分析 (SCF/C-kit,VIP-cAMP-PKA-AQP3).
评估短链脂肪酸 (SCFA) 生产和肠道微生物群组成.

主要成果:

饮食干预措施,包括蜂蜜油糊,改善了便秘.
蜂蜜糊在缓解便秘方面表现出最显著的效果.
改善与有益代谢物,特别是酸盐的产生增加以及特定肠道细菌 (Clostridium,Akkermansia,Bacteroides,Blautia) 的增殖有关.
观察到SCFA生产和肠道微生物群的变化,这表明在治疗效果中发挥了作用.

结论:

蜂蜜油糊是一种可行的,有效的干预措施来缓解便秘.
该机制涉及促进SCFA的产生和调节肠道微环境.
潜在的治疗目标包括微生物群操纵和SCFA用于便秘管理的管理.

关键词:

艾洛韦拉是一种.胃肠道功能胃肠道功能蜂蜜蜂蜜蜂蜜蜂蜜肠道微环境是什么意思慢过渡性便秘缓慢过渡性便秘

更多相关视频

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

相关概念视频

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

Drugs Affecting GI Tract Motility: Other Laxatives

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...